American Journal of Ophthalmology
Volume 141, Issue 1 , Pages 24-30 , January 2006

Categorizing the Stage of Glaucoma From Pre-Diagnosis to End-Stage Disease

This project was previously presented as a poster at the Association for Research in Vision and Ophthalmology (ARVO) May 5–10, 2001.

  • Richard P. Mills, MD, MPH

      Affiliations

    • University of Washington, Seattle, Washington
    • ,
  • Donald L. Budenz, MD

      Affiliations

    • Bascom Palmer Eye Institute, Miami, Florida
    • ,
  • Paul P. Lee, MD, JD

      Affiliations

    • Duke University, Durham, North Carolina
    • ,
  • Robert J. Noecker, MD, MBA

      Affiliations

    • University of Pittsburgh, Pittsburgh, Pennsylvania
    • ,
  • John G. Walt, MBA

      Affiliations

    • Allergan, Inc, Irvine, California
    • Corresponding Author InformationInquiries to John Walt, MBA, Allergan, 2525 Dupont Drive, Irvine, CA 92623-9534; fax: 714-246-4241
    • ,
  • Lisa R. Siegartel, MPH

      Affiliations

    • Analytica International, New York, New York
    • ,
  • Stacy J. Evans, MD

      Affiliations

    • Analytica International, New York, New York
    • ,
  • John J. Doyle, DrPH

      Affiliations

    • Analytica International, New York, New York

,Accepted 16 July 2005.

References 

  1. American Academy of Ophthalmology GP . Primary open-angle glaucoma. Preferred practice pattern . In: San Francisco: American Academy of Ophthalmology; 2000;p. 1–36
  2. Glick H , Brainsky A , McDonald RC , Javitt JC . The cost of glaucoma in the United States in 1988 . Chibret Int J Ophthalmol . 1994;10:6–12
  3. Kobelt-Nguyen G , Gerdtham UG , Alm A . Costs of treating primary open-angle glaucoma and ocular hypertension (a retrospective, observational two-year chart review of newly diagnosed patients in Sweden and the United States) . J Glaucoma . 1998;7:95–104
  4. Distelhorst JS , Hughes GM . Open-angle glaucoma . Am Fam Physician . 2003;67:1937–1944
  5. Riordan-Eva P , Vaughan DG . Eye . In:  Tierney LM ,  McPhee SJ ,  Papadakis MA editor. Current medical diagnosis and treatment . New York: Lange Medical Books/McGraw-Hill; 2001;p. 185–216
  6. Alward WL . Medical management of glaucoma . N Engl J Med . 1998;339:1298–1307
  7. Infeld DA , O’Shea JG . Glaucoma (diagnosis and management) . Postgrad Med J . 1998;74:709–715
  8. Barnebey H . Screening for glaucoma . In:  Fihn SD ,  DeWitt DE editor. Outpatient medicine . Philadelphia: Saunders; 1998;p. 119–120
  9. Advanced Glaucoma Intervention Study. 2. Visual field test scoring and reliability . Ophthalmology . 1994;101:1445–1455
  10. Katz J . Scoring systems for measuring progression of visual field loss in clinical trials of glaucoma treatment . Ophthalmology . 1999;106:391–395
  11. Chen PP , Park RJ . Visual field progression in patients with initially unilateral visual field loss from chronic open-angle glaucoma . Ophthalmology . 2000;107:1688–1692
  12. Musch DC , Lichter PR , Guire KE , Standardi CL . The Collaborative Initial Glaucoma Treatment Study (study design, methods, and baseline characteristics of enrolled patients) . Ophthalmology . 1999;106:653–662
  13. Mills RP , Drance SM . Esterman disability rating in severe glaucoma . Ophthalmology . 1986;93:371–378
  14. Hodapp E , Parrish RK , Anderson DR . Clinical decisions in glaucoma . In: St. Louis: Mosby; 1993;p. 53
  15. Katz J , Sommer A , Gaasterland DE , Anderson DR . Comparison of analytic algorithms for detecting glaucomatous visual field loss . Arch Ophthalmol . 1991;109:1684–1689
  16. Anderson DR . Automated static perimetry . St. Louis: Mosby; 1995;
  17. Janz N , Wren PA , Group CS . Implementing quality of life in a clinical trial (The Collaborative Initial Glaucoma Treatment Study) . In:  Anderson DR ,  Drance SM editor. Encounters in glaucoma research 3 (how to ascertain progression and outcome) . New York: Kugler Publications; 1996;p. 45–62
  18. American Medical Association . Guides to the Evaluation of Permanent Impairment . In: Chicago: American Medical Association; 1984;p. 141–151
  19. Quigley HA . Identification of glaucoma-related visual field abnormality with the screening protocol of frequency doubling technology . Am J Ophthalmol . 1998;125:819–829
  20. Evans C . The use of consensus methods and expert panels in pharmacoeconomic studies. Practical applications and methodological shortcomings . Pharmacoeconomics . 1997;12:121–129
  21. Torrance GW , Blaker D , Detsky A , et al.   Canadian guidelines for economic evaluation of pharmaceuticals. Canadian Collaborative Workshop for Pharmacoeconomics . Pharmacoeconomics . 1996;9:535–559
  22. Normand SL , McNeil BJ , Peterson LE , Palmer RH . Eliciting expert opinion using the Delphi technique (identifying performance indicators for cardiovascular disease) . Int J Qual Health Care . 1998;10:247–260
  23. Lomas J , Anderson G , Enkin M , Vayda E , Roberts R , MacKinnon B . The role of evidence in the consensus process. Results from a Canadian consensus exercise . JAMA . 1988;259:3001–3005
  24. Frances A , Kahn D , Carpenter D , Frances C , Docherty J . A new method of developing expert consensus practice guidelines . Am J Manag Care . 1998;4:1023–1029
  25. Wilkinson CP . Evidence-based medicine regarding the prevention of retinal detachment . Trans Am Ophthalmol Soc . 1999;97:397–404 discussion 404–406
  26. Pearson SD , Margolis CZ , Davis S , Schreier LK , Sokol HN , Gottlieb LK . Is consensus reproducible? A study of an algorithmic guidelines development process . Med Care . 1995;33:643–660
  27. Katz J , Congdon N , Friedman DS . Methodological variations in estimating apparent progressive visual field loss in clinical trials of glaucoma treatment . Arch Ophthalmol . 1999;117:1137–1142
  28. Ellish NJ , Higginbotham EJ . Evaluating a visual field screening test for glaucoma (how the choice of the gold standard affects the validity of the test) . Ophthalmic Epidemiol . 2001;8:297–307
  29. Burnstein Y , Ellish NJ , Magbalon M , Higginbotham EJ . Comparison of frequency doubling perimetry with Humphrey visual field analysis in a glaucoma practice . Am J Ophthalmol . 2000;129:328–333
  30. Mills RP , Barnebey HS , Migliazzo CV , Li Y . Does saving time using FASTPAC or suprathreshold testing reduce quality of visual fields? . Ophthalmology . 1994;101:1596–1603
  31. Oliver JE , Hattenhauer MG , Herman D , et al.   Blindness and glaucoma (a comparison of patients progressing to blindness from glaucoma with patients maintaining vision) . Am J Ophthalmol . 2002;133:764–772
  32. Lee PP, Walt JG, Doyle JJ, et al. A multi-center, retrospective pilot study of resource utilization and costs associated with severity of disease in glaucoma. Arch Ophthalmol 2005; Forthcoming.
  33. Zeyen T , Roche M , Brigatti L , Caprioli J . Formulas for conversion between Octopus and Humphrey threshold values and indices . Graefes Arch Clin Exp Ophthalmol . 1995;233:627–634
  34. Traverso CE, Walt JG, Kelley SP, et al. A multinational retrospective study of resource utilization and costs associated with glaucoma disease progression in Europe. Br J Ophthalmol 2005; Forthcoming.

 This study was supported by a research grant from Allergan, Inc., Irvine, California.

PII: S0002-9394(05)00817-2

doi: 10.1016/j.ajo.2005.07.044

American Journal of Ophthalmology
Volume 141, Issue 1 , Pages 24-30 , January 2006

Article Tools